Category: Anaemic Hypoxia

For media and investors only Issued: London, UK Approval marks a significant step in GSK’s global efforts to help patients with anaemia due to chronic kidney disease (CKD). GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral hypoxia-inducible factor prolyl...

Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease Sutimlimab, a novel investigational C1s inhibitor, has the potential to be the first approved treatment for cold agglutinin disease, a serious, chronic, rare blood disorder Results met the primary and secondary endpoints and demonstrated rapid inhibition of hemolysis and clinically significant improvements in anemia...

VIFOR PHARMA PRESS RELEASE IRON DEFICIENCY DAY 2019 For a fifth consecutive year, Iron Deficiency Day aims to inform about the impact and symptoms of iron deficiency Iron Deficiency Day 2019 encourages people to ‘take iron seriously’ Supported by the European Kidney Health Alliance, The Heart Failure Policy Network and the Anaemia Community focused on the impact of iron deficiency...

Abstract Oxygen must be transported effectively from the atmosphere to the tissues in order to sustain normal metabolism. An understanding of oxygen delivery is therefore central to the management of patients during anaesthesia, resuscitation and during critical illness. This review deals specifically with the transport of oxygen from the lungs to non-pulmonary tissues. Key points Oxygen is carried in arterial...